Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week placebo-controlled trial of LY2428757 in type 2 diabetes mellitus
2008-004207-63Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing LY2428757 once weekly with Placebo once weekly (2 arms). Primary endpoint: Change in HbA1c from baseline to endpoint. Started Nov 2008; status: completed.
02
Drugs
LY2428757
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-004207-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004207-63.